By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it will redeem all of its outstanding 3.25 percent convertible senior subordinated notes due 2024.

The firm said that $329,229,000 million in aggregate principal amount of the notes was outstanding as of Feb. 25, 2011. The notes will be redeemed on March 30 at 100 percent of their principal amount plus accrued and unpaid interest to the redemption date, said Thermo Fisher.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.